DEF: Nu Skin Enterprises Sets May 28, 2026 Annual Meeting

Nu Skin Enterprises, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for May 28, 2026, to elect directors, approve executive compensation, and ratify auditor selection.

Summary

• Nu Skin Enterprises, Inc. will hold its Annual Meeting of Stockholders on May 28, 2026, at its corporate offices in Provo, Utah.
• Key agenda items include the election of nine directors, an advisory vote on executive compensation, approval of the Amended and Restated 2024 Omnibus Incentive Plan, and ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2026.
• The record date for determining eligible stockholders is March 31, 2026.
• The company is seeking stockholder approval to increase the number of shares authorized under its equity incentive plan by 2,850,000 shares.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as neutral to slightly positive, highlighting ongoing governance practices and strategic plans, but also acknowledging past performance challenges and potential future dilution.

Positives

• The company is holding its annual meeting as scheduled, indicating ongoing operational stability.
• The board composition includes directors with diverse experience in digital marketing, finance, accounting, and the direct selling industry.
• The company has a robust corporate governance framework, including independent committees and clear risk oversight responsibilities.
• The executive compensation program is designed with a strong emphasis on pay-for-performance, with a significant portion of compensation tied to company and stock price performance.
• The company has implemented equity retention requirements for directors and executives to align their interests with stockholders.
• The company has a clawback policy and prohibits hedging and pledging of company securities by directors and employees.

Negatives

• The company experienced headwinds from its business transformation process in 2025, impacting adjusted revenue and adjusted operating income results.
• Cash incentive awards for financial goals in 2025 were not earned due to performance falling below minimum levels.
• The CEO pay ratio, when including all employees, is exceptionally high at 8,853:1, though the company provides a supplemental ratio of 137:1 excluding certain China sales employees.
• The company is requesting an increase in authorized shares for its equity incentive plan, which will increase dilution from 10.5% to 14.9% if approved.

Risks

• The company faces macroeconomic pressures impacting consumer spending and customer acquisition.
• The ongoing business transformation process has resulted in switching costs and business practice realignments.
• The company's reliance on its sales force and the effectiveness of its affiliate-focused programs are critical to its success.
• Potential dilution from the proposed increase in equity incentive plan shares could impact existing shareholders.
• The company's forward-looking statements are subject to risks and uncertainties, including political, legal, tax, and regulatory uncertainties, as well as economic conditions and competitive pressures.

Future Outlook

The company is focused on two major growth initiatives for 2026: launching its Prysm iO intelligent wellness platform and expanding into India. It aims to continue improving operational performance and efficiency to return value to stockholders.

Management Comments

• We continued to advance our vision of becoming the worlds leading beauty, wellness and lifestyle leadership opportunity platform.
• We were able to lay the groundwork for our two major growth initiatives for 2026: launching our Prysm iO intelligent wellness platform and expanding into India.
• We delivered results within our previously communicated guidance range and grew earnings per share through disciplined cost management and operational execution, as well as the sale of our Mavely business.
• While transitioning our business to enable our two strategic growth priorities has come with some inherent switching costs as our company and channel realign business practices, we believe these shifts are critical to our mid- to long-term success.
• As we pursue these strategic growth priorities, we will continue to drive our third critical priority of improving operational performance and efficiency to return value to stockholders.

Industry Context

StockSavvy.ai notes that Nu Skin Enterprises is operating in the competitive beauty, wellness, and lifestyle direct selling industry. The company's focus on digital platforms and strategic growth initiatives like the Prysm iO launch and India expansion are key trends within the sector.

Management Changes

Corporate Governance

Related Party Transactions

• Cade Napierski, brother of CEO Ryan Napierski, received approximately $401,000 in compensation (salary, bonuses, equity) in 2025 and participated in employee benefit plans.

Stakeholder Impact

• Stockholders will vote on key corporate matters, including director elections and compensation, influencing future company direction.
• Employees and executives will continue to be incentivized through equity awards, with the proposed increase in shares potentially impacting dilution.
• The company's strategic initiatives and operational performance will impact its ability to deliver value to all stakeholders.

Next Steps

• Stockholders to vote on the election of directors, executive compensation, the Amended and Restated 2024 Omnibus Incentive Plan, and the ratification of the independent auditor.
• The company will continue to implement its strategic growth priorities for 2026, including the launch of the Prysm iO intelligent wellness platform and expansion into India.

Key Dates

Recommendation

The company's strategic initiatives and improved gross margins are positive, but past performance challenges and the potential for increased dilution from the equity plan warrant a cautious 'hold' recommendation. Investors should monitor the success of the Prysm iO launch and India expansion.

Keywords

Nu Skin Enterprises, Proxy Statement, Annual Meeting, Director Election, Executive Compensation, Omnibus Incentive Plan, Independent Auditor, Corporate Governance, Equity Awards, Stockholder Vote